Maximum Strength Zephrex-D, Pseudoephedrine HCl, 30 mg, Nasal Decongestant. 24 softgel tablets per paper carton, Distributed by Perrigo, Allegan, MI 49010, NDC 70085-151-01
Published December 27, 2017 · Recall initiated: November 8, 2017
Summary
FDA records drug Class II recall D-0128-2018, published December 27, 2017 and initiated November 8, 2017. Recalling firm: L. Perrigo Company; Status: Terminated; Reported quantity: 19,944 Cartons (24 tablets each); Lot: Lot # AF4273A; Exp. 02/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-Sterile Products
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- L. Perrigo Company
- Distributor
- Nationwide
- Lot
- Lot # AF4273A; Exp. 02/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAllergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDCJuly 19, 2023
- FDAallergyrelief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)30-count cartons (NDC 56062-847-39);July 19, 2023
- FDAallergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22),July 19, 2023
- FDAallergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 79481-0847-0),July 19, 2023
- FDACiprofloxacin in Dextrose (5%) Injection, USP 200 mg in 100 mL 5% Dextrose, Rx Only, (2 mg/mL), 100 mLDecember 27, 2017
- FDANeostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use OnlyDecember 27, 2017
Questions about this recall
Was Maximum Strength Zephrex-D, Pseudoephedrine HCl, 30 mg, Nasal Decongestant. 24 softgel tablets per paper carton, Distributed by Perrigo, Allegan, MI 49010, NDC 70085-151-01 recalled?
Yes. FDA published recall D-0128-2018 on December 27, 2017. Reported hazard: Microbial Contamination of Non-Sterile Products
What should I do if I have this product?
Voluntary: Firm initiated · Letter